IndraLab

Statements



reach
"The majority of patients were treated with antithrombotic therapy at screening : 103 (68%) with heparin and 110 (72%) with aspirin, 43 (28%) were treated with hydroxychloroquine, and immunosuppressive therapy was infrequent."